Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Therapy
Scientists at New York University target HIV/AIDS therapy
August 6th, 2008
Scientists discuss in 'Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia' new findings in HIV/AIDS. According to a study from the United States, "We assessed the effect of progressively longer antiretroviral structured treatment interruptions (STIs) starting with 3 days, increasing by 2 days in length each cycle on HIV-specific immune responses. As well, we correlated these responses with control of HIV viremia." "Eight individuals became viremic and reached cycle 13 with an STI of >or=27 days. HIV-specific gamma-interferon production to inactivated HIV and vaccinia vectors...
Source: Vaccine Weekly (2008-08-06)
|
